Federal Circuit Affirms: Monoclonal Antibodies Are Not Infringed
WASHINGTON, D.C. — Findings in favor of a declaratory judgment plaintiff that patented monoclonal antibodies are not infringed by chimeric and humanized antibodies found in the “Cimzia” anti-inflammatory drug will stand...To view the full article, register now.
Already a subscriber? Click here to view full article